T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
Stopped Replaced by a new study
Conditions
- Hematologic Malignancy
- Acute Myeloid Leukemia
- Acute Lymphocytic Leukemia
- Chronic Myelogenous Leukemia in Blast Crisis
- Anemia, Refractory, With Excess of Blasts
- Chronic Myeloproliferative Disease
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Marginal Zone B-cell Lymphoma
- Follicular Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle-Cell Lymphoma
- Prolymphocytic Lymphoma
- Large Cell Non-Hodgkin's Lymphoma
- Lymphoblastic Lymphoma
- Burkitt's Lymphoma
- High Grade Non-Hodgkin's Lymphoma
Interventions
- BIOLOGICAL: Treg cells
- BIOLOGICAL: CD3+ Teff cells
- DRUG: Fludarabine
- DRUG: Cyclophosphamide
- RADIATION: Total body irradiation
- BIOLOGICAL: Umbilical cord blood transplantation
Sponsor
Masonic Cancer Center, University of Minnesota